Trends in US autism research funding.

Singh et al. (2009) counted every US autism research grant from 1997 to 2006. They sorted each grant as basic science, translational, or clinical. Then they tracked how the money moved across those bins over the decade.

Autism funding grew about 15 percent every year. Basic-science grants lost share while translational and clinical grants gained share. The field was shifting money toward studies that test real-world help.

den Houting et al. (2019) later did the same count for Australia 2008-2017 and saw the same tilt toward translational work. Their data extend the US trend to another country and decade.

Evenhuis (1996) had sketched a wish list heavy on basic genetics and brain imaging. Jennifer et al. show dollars actually moved the opposite way—toward trials and services—making the 1996 paper a baseline the funding market did not follow.

Amaral et al. (2019) asked global experts what still gets missed. They flagged heterogeneity and culture as gaps, echoing the need for more translational and community-based studies that the funding shift now enables.

If you write grants, follow the money. Proposals that move from lab to clinic now face less basic-science competition. Pair with service agencies or schools to show clear client benefit and your odds rise.